Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (101-110 of 308) with videos related to

Pageof 31
Sort By:
Clinical Drug Investigation|July 6, 2014
Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological responseJörg Kleine-Tebbe, Mikkel Walmar, Klaus Bitsch-Jensen, et al.
Allergy|May 24, 2021
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysisOliver Pfaar, Bernardo Sousa-Pinto, Philippe Devillier, et al.
Molecular Immunology|February 22, 2023
Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profilingThierry Batard, Walter G Canonica, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 16, 2023
Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts' PerspectiveOliver Pfaar, Jay Portnoy, Hendrik Nolte, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2018
UK Immunotherapy Study: Reanalysis by a combined symptom and medication scoreAnthony J Frew, Christian Ljørring, Hendrik Wolf, et al.
Neuroimmunomodulation|February 9, 2026
Experimental approach to inducing anti-histaminergic placebo effects - A randomized controlled trial in healthy volunteersStefanie Hölsken, Eva Holubek, Frederik Krefting, et al.
Allergy|June 3, 2020
The need for improved transition and services for adolescent and young adult patients with allergy and asthma in all settingsGraham Roberts, Marta Vazquez-Ortiz, Ekaterina Khaleva, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 28, 2015
The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient surveyMoises A Calderon, Linda Cox, Thomas B Casale, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 23, 2012
Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled studyPaul K Keith, Andrzej Dymek, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2015
Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus reportJames T Li, David I Bernstein, Moises A Calderon, et al.
Pageof 31

Showing results (101-110 of 308) with videos related to

Sort By:
Pageof 31
Clinical Drug Investigation|July 6, 2014
Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological responseJörg Kleine-Tebbe, Mikkel Walmar, Klaus Bitsch-Jensen, et al.
Allergy|May 24, 2021
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysisOliver Pfaar, Bernardo Sousa-Pinto, Philippe Devillier, et al.
Molecular Immunology|February 22, 2023
Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profilingThierry Batard, Walter G Canonica, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 16, 2023
Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts' PerspectiveOliver Pfaar, Jay Portnoy, Hendrik Nolte, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2018
UK Immunotherapy Study: Reanalysis by a combined symptom and medication scoreAnthony J Frew, Christian Ljørring, Hendrik Wolf, et al.
Neuroimmunomodulation|February 9, 2026
Experimental approach to inducing anti-histaminergic placebo effects - A randomized controlled trial in healthy volunteersStefanie Hölsken, Eva Holubek, Frederik Krefting, et al.
Allergy|June 3, 2020
The need for improved transition and services for adolescent and young adult patients with allergy and asthma in all settingsGraham Roberts, Marta Vazquez-Ortiz, Ekaterina Khaleva, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 28, 2015
The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient surveyMoises A Calderon, Linda Cox, Thomas B Casale, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 23, 2012
Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled studyPaul K Keith, Andrzej Dymek, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2015
Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus reportJames T Li, David I Bernstein, Moises A Calderon, et al.
Pageof 31